Patients with inflammatory bowel disease (IBD) have a high resource consumption, with considerable costs for the healthcare system.
In a system with sparse resources, treatment is influenced not only by clinical judgement but also by resource consumption.
Dr Michael Sulz and colleagues determined the resource consumption of IBD patients and to identify its significant predictors.
Data from the prospective Swiss Inflammatory Bowel Disease Cohort Study were analyzed for the resource consumption endpoints hospitalization and outpatient consultations at enrolment, and at 1-year follow-up.
|C-reactive protein was predictive for hospitalization days|
|European Journal of Gastroenterology & Hepatology|
Predictors of interest were chosen through an expert panel and a review of the relevant literature.
For Crohn's disease, fistula, use of biologics and disease activity were significant predictors for hospitalization days.
The research team found that age, sex, steroid therapy and biologics were significant predictors for the number of outpatient visits.
For ulcerative colitis, biologics, C-reactive protein, smoke quitters, age and sex were significantly predictive for hospitalization days.
The researchers found that disease activity and immunosuppressive therapy predicted the number of outpatient visits.
Dr Sulz's team concludes, "Several highly significant clinical predictors for resource consumption in IBD were identified that might be considered in medical decision-making."
"In terms of resource consumption and its predictors, Crohn's disease and ulcerative colitis show a different behavior."